Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention.(Molecole di Adesione Nella Sindrome Coronarica Acuta

NCT01757457 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria Maggiore della Carita as lead sponsor.

NCT NCT01757457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention.(Molecole di Adesione Nella Sindrome Coronarica Acuta
Lead sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
April 30, 2008
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction